Most founders weigh SBIR Phase 2 against doing nothing. That is the wrong comparison.
The real comparison is SBIR Phase 2 against the next-best use of the same 24 months: raising and deploying a seed round. When you frame it that way, the answer changes for a lot of VC-track companies. Here is the math nobody runs.
The short answer
SBIR Phase 2 vs a seed round comes down to opportunity cost, not the application fee. Phase 2 gives you roughly $1M to $2M with zero dilution but costs 6 to 12 months of CEO attention and arrives slowly. A $2M seed round closes in 3 to 6 months and deploys immediately, but costs 15 to 25 percent of your company. Phase 2 wins for capital-intensive, dual-use, or pre-VC companies. A seed round wins when speed and optionality matter more than ownership. For many founders, the right answer is running both in parallel.
That is the 60-second version. The rest of this piece shows you how to run the comparison for your specific burn rate and runway.
Why nobody runs this math
SBIR advice almost always comes from people who get paid when you apply. Grant consultants, application platforms, accelerators with a non-dilutive pitch. None of them benefit from telling you to skip the program and raise instead.
VC advice has the opposite bias. Investors and the founders who took their money tend to treat non-dilutive capital as a distraction from "the real game" of venture scale.
Neither side runs the honest comparison, because the honest comparison makes both of them look optional in some cases.
The cost that gets ignored is CEO time. Non-dilutive capital has a $0 sticker price, so founders treat it as free money. It is not free. It costs the scarcest resource you have: the 24 months of founder attention that could have gone into a fundraise, a product sprint, or a go-to-market push.
Opportunity cost, for a founder, is simple: what is the best thing you could do with the same time and attention that Phase 2 will consume? If that best alternative creates more enterprise value than Phase 2, then Phase 2 is a loss even if you win the award.
The two clocks: SBIR Phase 2 vs a seed round over 24 months
The clearest way to see the tradeoff is to put both paths on the same 24-month timeline.
| Dimension | SBIR Phase 2 | $2M Seed Round |
|---|---|---|
| Capital available | ~$1M to $2M (varies by agency) | ~$2M |
| Dilution | 0% | 15% to 25% |
| Time to first cash | 6 to 12 months from submission | 3 to 6 months from kickoff |
| CEO time load | Heavy at proposal + milestone reporting | Heavy at raise, light after close |
| Strings attached | Milestone deliverables, audits, federal contracting | Board seat, investor reporting, growth pressure |
| What it signals | Technical validation to government and some VCs | Market validation to customers and future investors |
| Speed of deployment | Constrained by reporting and scope | Immediate, unconstrained |
Both paths put roughly the same dollars in your account over the period. The difference is what each one costs you to get there and what it does to your timeline.
A seed round front-loads the pain: 3 to 6 months of brutal fundraising, then capital you can deploy however you want. SBIR Phase 2 spreads the pain across the whole period through milestone reporting and scope constraints, and the cash arrives slower.
How big is the funding gap between Phase 1 and Phase 2?
Here is the part that kills companies that "won" SBIR.
The funding gap between Phase 1 and Phase 2 is the dead zone between when your Phase 1 money runs out and when your Phase 2 money arrives. For a 6-person team burning $80K per month, this gap peaks around a $1M cash need near month 22 if you are relying on SBIR alone.
The arithmetic is unforgiving. An NIH Phase I award is about $275K. A typical DoD or AFWERX Phase I runs $150K to $300K. At $80K per month burn, $275K covers roughly 3.5 months of a 6-person team, maybe 6 months if you stretch.
Phase 1 performance periods run 6 to 12 months. Then you write the Phase 2 proposal, wait for the review cycle, wait for selection, and wait for the contract. That is another 6 to 12 months before Phase 2 cash hits.
Do the subtraction. Your Phase 1 money is gone months before your Phase 2 money arrives. Something has to fund the gap, and it is usually $500K to $1M+. Founders who did not plan for this either burn personal savings, take a bridge note on bad terms, or quietly fold a company that technically won two federal awards.
This gap is the single strongest argument for not treating SBIR as a standalone funding strategy if you have a real burn rate. It is also the single strongest argument for pairing it with dilutive capital that can cover the dead zone.
Does SBIR Phase 2 actually help you raise venture capital?
This is where the evidence gets interesting, and where most founders are working off a myth.
The best causal evidence comes from Sabrina Howell's regression-discontinuity study of Department of Energy SBIR applicants, published in the American Economic Review in 2017. By comparing firms that barely won against firms that barely lost, Howell isolated the actual effect of the award rather than the quality of the company.
The Phase I finding is strong: an early-stage Phase I award roughly doubles the probability of subsequent venture capital for financially constrained firms. The signal is real, and it is concentrated in companies that would have struggled to raise privately.
The Phase II finding is the one nobody quotes. For the marginal firms in Howell's data, the ones right at the funding threshold, Phase II showed no measurable effect on commercial outcomes, except a small bump in citation-weighted patents. One caveat worth stating plainly: a regression-discontinuity design measures the effect on companies near the win/lose cutoff, not the average across every Phase II recipient. So read this as "Phase II did not move the needle for borderline firms," not "Phase II never helps anyone." The big signaling value still lives in Phase I, not Phase II.
There is a selection pattern that points the same way. Roughly 40 percent of Phase I winners never apply to Phase II (a figure consistent with SBA program data and noted in the Howell-lineage research), and the non-applicants skew toward firms that already raised VC. The founders with venture capital looked at Phase II and walked away. They had already extracted the signal they needed, and the opportunity cost of two more years of milestone reporting was not worth it to them.
The decision rule that falls out of this: if your main reason for Phase 2 is the validation signal, and you already have VC, the signal is largely spent. You are paying 24 months of CEO time for a credibility bump you mostly already collected in Phase 1.
I should flag the limits here. Howell's data is DoD and DOE energy-tech weighted, and a 2025 follow-up on Air Force open-topic awards is still being digested by researchers. The Phase I signaling effect replicates well. The Phase II null result is the part to hold loosely if your agency or sector is very different from energy hardware.
When Phase 2 is strictly worse than a round
For some companies, Phase 2 is not a tradeoff. It is just the worse option. Skip it if most of these are true:
- You have term sheet optionality or warm VC interest you could convert in the next two quarters.
- Your burn is above $80K per month, so the funding gap will hit you hard.
- Your product needs fast iteration and the milestone scope would lock you into a plan you will want to change.
- Your market is timing-sensitive and a 6 to 12 month cash delay means a competitor gets there first.
- You already won a Phase I and collected the validation signal.
The hidden tax in all of these is CEO time. A Phase 2 cycle is not a one-time application. It is the proposal, then milestone reporting, then dealing with a contracting officer, then audit prep. Plan on 6 to 12 months of part-time CEO load spread across the period.
For a company that could raise instead, those are the exact same months you needed for the fundraise and the product push the round was supposed to fund. You cannot spend them twice.
When Phase 2 beats a round
Now the other side. Phase 2 wins, often decisively, when:
- You are capital-intensive hardware where a $2M round at a $10M post means giving up 20 percent for money that barely funds one build cycle. Non-dilutive $2M is worth far more than dilutive $2M here.
- You are dual-use or selling to a government customer, and Phase 2 doubles as a procurement on-ramp that a seed round cannot buy.
- Your technical risk is the kind VCs will not fund yet. They want to see the de-risking that Phase 2 pays for.
- You are pre-revenue with no clean VC story, and a federal award is the most credible third-party validation available to you right now.
The dilution math is the cleanest argument. Take $2M at a $10M post-money valuation. That round costs you 20 percent of your company. If the company is later worth $200M, that 20 percent was worth $40M. The same $2M from Phase 2 costs you zero equity and a couple of years of reporting overhead. For a company that is genuinely going to be worth a lot, non-dilutive capital is one of the best deals available, if you can survive the timeline.
The portfolio answer: when it is both
Here is the framing the SBIR-only consultants and the VC-only crowd both miss, because it does not fit either sales motion: for many deep-tech companies, the right answer is to run both in parallel.
The two instruments do different jobs. A seed round funds burn and speed and gives you capital you control. SBIR Phase 2 funds technical de-risking and, for dual-use companies, a procurement bridge, without diluting you further.
Used together, the seed round can fund the Phase 1 to Phase 2 gap that would otherwise kill you, while Phase 2 stretches the round by covering R&D you would have paid for with equity dollars. The round buys speed; the grant buys runway extension and de-risking. That is a portfolio, not a coin flip.
The constraint is CEO attention, and it is real. You cannot run a fundraise and write a Phase 2 proposal in the same six weeks without one of them suffering. The portfolio answer only works if you sequence it: raise first or submit first, never both at the peak of their CEO-time demand.
The runway-aware version of the question is this: can your runway bridge the Phase 2 funding gap while you also run a fundraising process? If yes, parallel is usually the highest-value path. If no, you have to pick one, and the burn-versus-timeline math tells you which.
How to actually run the comparison
You do not need a spreadsheet genius for this. You need five numbers and 30 minutes.
- Compute your monthly burn. Total monthly cash out, fully loaded. Call it B.
- Map both timelines against your runway. SBIR Phase 2: 6 to 12 months to first cash, plus the Phase 1 gap if you are mid-sequence. Seed round: 3 to 6 months to close. Mark where each one runs you to zero cash.
- Compute the dilution cost of the round. Round size divided by post-money valuation gives the percentage. Multiply by a realistic future company value to see the dollar cost of that equity.
- Compute the CEO-hour cost of Phase 2. Estimate the founder hours across proposal, reporting, and contracting over the period. Multiply by what an hour of your attention is worth at this stage. It is more than you think.
- Compare net value, not gross capital. Both paths land roughly the same dollars. The decision is which one costs you less in dilution, time, and timeline risk given your specific runway.
If your runway cannot survive the SBIR timeline, the comparison is over: you raise, or you find bridge capital first. If your runway is comfortable and you are capital-intensive or dual-use, Phase 2 or the portfolio play usually wins. The middle is where it is genuinely a judgment call, and that is where running the actual numbers beats following anyone's default advice.
Frequently asked questions
Is SBIR Phase 2 worth it if I already have a term sheet?
Usually not as a standalone move. Howell's evidence shows the VC-signaling value is concentrated in Phase I, and roughly 40 percent of Phase I winners never apply to Phase II at all, with the non-applicants skewing toward firms that already raised VC. If you have a term sheet, the signal is mostly spent. Phase 2 only makes sense alongside the round if you are capital-intensive or dual-use and can run both without starving either.
How long does SBIR Phase 2 take to get paid?
Plan on 6 to 12 months from submission to first cash, depending on agency and whether your timing lines up with a review cycle. That delay, stacked on top of a Phase 1 performance period, is what creates the funding gap.
Can you raise a seed round and run SBIR Phase 2 at the same time?
Yes, and for many deep-tech companies it is the best path. The round covers burn and the Phase 1 to Phase 2 gap; the grant extends runway and de-risks technology without dilution. The catch is CEO time. You have to sequence the peak-effort weeks so the fundraise and the proposal do not collide.
How big is the funding gap between Phase 1 and Phase 2?
For a 6-person team at $80K per month burn, the gap peaks around a $1M cash need near month 22 if you rely on SBIR alone. A Phase I award covers roughly 6 months; the wait for Phase 2 cash is another 6 to 12 months. The dead zone in between is where companies that won SBIR run out of money.
Does SBIR count as dilution?
No. SBIR awards are non-dilutive. You give up no equity. The cost is CEO time, milestone and reporting obligations, and a slower cash timeline, not ownership.
Should you run Phase 2, raise, or do both?
If you are weighing SBIR Phase 2 against a seed round, the honest answer depends on three numbers: your monthly burn, your VC optionality, and whether your runway can bridge the Phase 2 gap. Most founders never run that comparison because nobody selling to them is incentivized to.
Cada builds non-dilutive grant portfolios designed to complement a raise, not replace it. We start with a free runway-and-pathway audit: we map your burn against the actual cycle times of the programs you qualify for, and we tell you straight if Phase 2 is the wrong move for your runway. No pitch, no obligation. If the math says raise instead, that is what we will tell you.